Novasep Appoints New President of Synthesis Business Unit - - BioPharm International

ADVERTISEMENT

Novasep Appoints New President of Synthesis Business Unit



Novasep, a supplier of manufacturing solutions to the life sciences industry, has appointed Thierry van Nieuwenhove as president of the synthesis business unit.
Van Nieuwenhove holds a Master's degree in chemistry and biochemistry from the Catholic University of Louvain, Belgium. Van Nieuwenhove joins Novasep from Ajinomoto-Omnichem, a European synthetic molecules custom manufacturing organization, where he held positions as director, general manager, and member of the board.

Source: Novasep

blog comments powered by Disqus

ADVERTISEMENT

ADVERTISEMENT

First Biosimilar Application Kicks Off Legal Battle
October 31, 2014
FDA Approves Pfizer's Trumenba for the Prevention of Meningitis B
October 30, 2014
EMA: Extrapolation Across Indications for Biosimilars a Possibility
October 30, 2014
Bristol-Myers Squibb Announces Agreement to Acquire HER2-Targeted Cancer Treatment
October 29, 2014
Amgen, Sanofi, and Ono Pharmaceuticals Partner with Universities on Transmembrane Protein Research
October 28, 2014
Author Guidelines

Click here